Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort

Biomarkers for the lung cancer diagnosis and their advances in proteomics

(2011) Hye-Jin Sung et al.   BMB Reports

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer

(2010) Mauro Antonio Alves Castro et al.   CANCER

Importance of cofilin oxidation for oxidant-induced apoptosis

(2010) Stéphanie Zdanov et al.   CELL CYCLE

ADF/Cofilin: a functional node in cell biology

(2010) Barbara W. Bernstein et al.   TRENDS IN CELL BIOLOGY

The New Lung Cancer Staging System

(2009) Frank C. Detterbeck et al.   CHEST

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data

(2009) Giannis Mountzios et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2009) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin

(2009) Fábio Klamt et al.   NATURE CELL BIOLOGY

Individualized therapy in non-small-cell lung cancer: future versus current clinical practice

(2009) R Pérez-Soler   ONCOGENE

The cancer biomarker problem

(2008) Charles L. Sawyers   NATURE